CRIF1 Anti-Cancer and Anti-Metastasis Composition Comprising CRIF1 Antagonist

摘要

The present invention relates to a composition effective for inhibiting anticancer and cancer metastasis by inhibiting cell migration, and more particularly, comprising an inhibitor of expression of CRIF1 (CR6 interacting factor 1) gene or an inhibitor of activity of CRIF1 protein as an active ingredient. It relates to a pharmaceutical composition for anticancer and cancer metastasis inhibition.